scholarly journals Patient Perceptions of Video Visits Using Veterans Affairs Telehealth Tablets: Survey Study

10.2196/15682 ◽  
2020 ◽  
Vol 22 (4) ◽  
pp. e15682 ◽  
Author(s):  
Cindie Slightam ◽  
Amy J Gregory ◽  
Jiaqi Hu ◽  
Josephine Jacobs ◽  
Tolessa Gurmessa ◽  
...  

Background Video-based health care can help address access gaps for patients and is rapidly being offered by health care organizations. However, patients who lack access to technology may be left behind in these initiatives. In 2016, the US Department of Veterans Affairs (VA) began distributing video-enabled tablets to provide video visits to veterans with health care access barriers. Objective This study aimed to evaluate veterans’ experiences with VA-issued tablets and identify patient characteristics associated with preferences for video visits vs in-person care. Methods A baseline survey was sent to the tablet recipients, and a follow-up survey was sent to the respondents 3 to 6 months later. Multivariate logistic regression was used to identify patient characteristics associated with preferences for care, and we examined qualitative themes around care preferences using standard content analysis methods for coding the data collected in the open-ended questions. Results Patient-reported access barriers centered around transportation and health-related challenges, outside commitments, and feeling uncomfortable or uneasy at the VA. Satisfaction with the tablet program was high, and in the follow-up survey, approximately two-thirds of tablet recipients preferred care via a tablet (194/604, 32.1%) or expressed that video-based and in-person care were “about the same” (216/604, 35.7%), whereas one-third (192/604, 31.7%) indicated a preference for in-person care. Patients were significantly more likely to report a preference for video visits (vs a preference for in-person visits or rating them “about the same”) if they felt uncomfortable in a VA setting, reported a collaborative communication style with their doctor, had a substance use disorder diagnosis, or lived in a place with better broadband coverage. Patients were less likely to report a preference for video visits if they had more chronic conditions. Qualitative analyses identified four themes related to preferences for video-based care: perceived improvements in access to care, perceived differential quality of care, feasibility of obtaining necessary care, and technology-related challenges. Conclusions Many recipients of VA-issued tablets report that video care is equivalent to or preferred to in-person care. Results may inform efforts to identify good candidates for virtual care and interventions to support individuals who experience technical challenges.

2008 ◽  
Vol 35 (6) ◽  
pp. 583-587 ◽  
Author(s):  
Alia A. Al-Tayyib ◽  
William C. Miller ◽  
Susan M. Rogers ◽  
Peter A. Leone ◽  
Dionne C. Gesink Law ◽  
...  

Cancer ◽  
2015 ◽  
Vol 121 (13) ◽  
pp. 2207-2213 ◽  
Author(s):  
George L. Jackson ◽  
Leah L. Zullig ◽  
Sean M. Phelan ◽  
Dawn Provenzale ◽  
Joan M. Griffin ◽  
...  

2020 ◽  
Author(s):  
J. Jeffery Reeves ◽  
John W. Ayers ◽  
Christopher A. Longhurst

UNSTRUCTURED The telehealth revolution has been heralded for its potential to improve health care access and improve the efficiency of health care delivery. However, virtual patient care can bring unintended consequences that eclipse the benefits including potentially limiting the patient-provider relationship, the quality of the examination, the efficiency of healthcare delivery, and the overall quality of care. Facing the most rapidly adopted medical trend in modern history, clinicians are beginning to grasp its possibilities, but we also need to understand its boundaries. As outcomes are studied and federal regulations reconsidered, it is important to be precise in the approach to the virtual patient encounter. We offer some simple guidelines to assist providers in determining the appropriateness of a telehealth visit, considering visit types, chief complaint or disease states, and patient characteristics.


2011 ◽  
Vol 22 (2) ◽  
pp. 562-575 ◽  
Author(s):  
J. Emilio Carrillo ◽  
Victor A. Carrillo ◽  
Hector R. Perez ◽  
Debbie Salas-Lopez ◽  
Ana Natale-Pereira ◽  
...  

10.2196/24785 ◽  
2021 ◽  
Vol 23 (2) ◽  
pp. e24785
Author(s):  
J Jeffery Reeves ◽  
John W Ayers ◽  
Christopher A Longhurst

The telehealth revolution in response to COVID-19 has increased essential health care access during an unprecedented public health crisis. However, virtual patient care can also limit the patient-provider relationship, quality of examination, efficiency of health care delivery, and overall quality of care. As we witness the most rapidly adopted medical trend in modern history, clinicians are beginning to comprehend the many possibilities of telehealth, but its limitations also need to be understood. As outcomes are studied and federal regulations reconsidered, it is important to be precise in the virtual patient encounter approach. Herein, we offer some simple guidelines that could assist health care providers and clinic schedulers in determining the appropriateness of a telehealth visit by considering visit types, patient characteristics, and chief complaint or disease states.


2017 ◽  
Vol 35 (15_suppl) ◽  
pp. 5048-5048
Author(s):  
Jennifer Cullen ◽  
Huai-Ching Kuo ◽  
Lauren Hurwitz ◽  
Inger L. Rosner ◽  
Timothy Rebbeck ◽  
...  

5048 Background: Disparity in prostate cancer (CaP) incidence and mortality for African American (AA) versus Caucasian American (CA) men may reflect tumor biology, comorbidity, treatment, follow-up care, and/or health care access. In a racially diverse cohort of patients undergoing radical prostatectomy (RP), this study examined how race, comorbidity, and PSA doubling time (PSADT) impact CaP progression. Methods: Enrollees in the Center for Prostate Disease Research (CPDR) Multi-Center National Database from 1989-2014 who underwent RP within 12 months of CaP diagnosis were eligible. Biochemical recurrence (BCR) was defined as PSA ≥0.2 ng/mL post-RP. Comorbid conditions included coronary artery disease (CAD), cerebral vascular incident (CVI), Type II diabetes (DB), hypertension (HT), elevated cholesterol (EC), lung disease (COPD), prostatitis (PS), renal insufficiency (RI) and other cancer (OC). Multivariable Cox proportional hazards (PH) analysis was used to examine comorbid conditions (yes vs. no) and PSADT ( < 3, 3-8.9, 9-14.9, and ≥15 mos) to predict BCR, controlling for age at RP, D’Amico risk stratum, pathology features, and adjuvant treatment. Results: A total of 6,785 patients were eligible; 22% AA and 78% CA. Median age and follow-up was 62 and 6.1 years, respectively. Across race, comparable median follow-up time, distributions of pathologic features and adjuvant treatments were observed. However, AA vs. CA patients had greater HT (53 vs. 39% p < 0.0001), DB (17 vs. 7%, p < 0.0001), and RI (3 vs. 1%, p = 0.002). Alternatively, CA vs. AA patients had greater CVD (10 vs. 7%, p = 0.0008) and OC (3 vs. 0.5%, p < 0.0001). Cox PH analysis showed poorer BCR-free survival for AA vs. CA men (HR = 1.28, CI = 1.11, 1.48, p = 0.0009) adjusting for D’Amico risk stratum, pathology, and treatment. PSADT, not comorbidity, was a critical predictor of BCR, with poorest outcome at extremes: HR PSADT < 3 vs. > = 15 months = 41.5, CI = 33.6, 51.3, p < 0.0001). Conclusions: Despite comparable health care access and distribution in clinical risk stratum and pathology features, race persisted in predicting poor CaP outcome. Disparate comorbidity for AA and CA men did not eliminate this difference. PSADT remained the most striking determinant of poor BCR-free survival.


Sign in / Sign up

Export Citation Format

Share Document